HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

Emerging small and medium-sized biotechs often face familiar constraints, with many hindered by the limited availability of resources. Consequently, they frequently lack the in-house capacity and breadth of expertise required to optimally navigate the transition from preclinical and clinical development to commercial success. Nonetheless, the pressure to quickly demonstrate value and progress remains unchanged, particularly in the face of growing uncertainty in the biotech landscape. As a result, it is increasingly evident that traditional consulting models are inadequate and limited in their ability to support client needs in continuously evolving and complex global markets.
This content was provided by Genesis Research Group
Company Details
Latest Content from Genesis Research Group
New Genesis Research Group CEO David W. Miller explains what we mean when we say we help our life science clients to ‘Innovate differently’ and transform the way they engage…
Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive…
A presentation with Katrin Nather, PhD, Associate Director, and Tijana Ignjatovic, Executive Director, Genesis Research Group. Contact solutions@genesisrg.com or visit www.genesisrg.com. With more and more innovative vaccines and immunization strategies…
This webinar reviews considerations for the design and data selection for RWE studies, including external control arm studies, to meet regulatory and HTA needs. Regulators and agencies responsible for market…
On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar…
